Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15464314 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis
Condition: Coronary Disease
Interventions: Device: Rapamycin-eluting Stent;   Device: Zotarolimus-eluting Stent

Indicates status has not been verified in more than two years